In addition, palmitoylated EGFR in TKI‐resistant EGFR‐mutant NSCLC cells positively regulates FASN and further promotes cancer cell growth through the Akt pathway.693. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.